Hematopoietic stem-cell transplantation for sickle cell disease: Current evidence and opinions

Therapeutic Advances in Hematology

Volumn 4, Issue 5, 2013, Pages 335-344

  Shenoy, Shalini ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

hematopoietic stem cell transplantation; sickle cell disease

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; FLUDARABINE; MELPHALAN; RAPAMYCIN;

ACUTE CHEST SYNDROME; ALLOIMMUNIZATION; ARTICLE; AVASCULAR NECROSIS; BONE NECROSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DISEASE COURSE; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; KIDNEY DISEASE; MORTALITY; PRIAPISM; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; TRICUSPID VALVE REGURGITATION;

EID: 84993748450     PISSN: 20406207     EISSN: 20406215     Source Type: Journal    
DOI: 10.1177/2040620713483063     Document Type: Article

References (61)

1. Adamkiewicz T. Boyer M. Bray R. Haight A. Yeager A. (2006) Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease. J Pediatr Hematol Oncol 28: 29–32.
2. Adamkiewicz T. Mehta P. Boyer M. Kedar A. Olson T. Olson E. et al. (2004) Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease. Bone Marrow Transplant 34: 405–411.
3. Amendah D. Mvundura M. Kavanagh P. Sprinz P. Grosse S. (2010) Sickle cell disease-related pediatric medical expenditures in the US Am J Prev Med 38(4 Suppl.): S550–S556.
4. Barker J. Byam C. Kernan N. Lee S. Hawke R. Doshi K. et al. (2010) Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biol Blood Marrow Transplant 16: 1541–1548.
5. Bernaudin F. Socie G. Kuentz M. Chevret S. Duval M. Bertrand Y. et al. (2007) Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 110: 2749–2756.
6. Bernaudin F. Verlhac S. Arnaud C. Kamdem A. Chevret S. Hau I. et al. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 117: 1130–1140.
7. Bolaños-Meade J. Fuchs E. Luznik L. Lanzkron S. Gamper C. Jones R. et al. (2012) HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood 120: 4285–4291.
8. Bunn H. Nathan D. Dover G. Hebbel R. Platt O. Rosse W. et al. (2010) Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116: 687–692.
9. Chakrabarti S. Bareford D. (2007) A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 39: 447–451.
10. Chu R. Brazauskas R. Kan F. Bashey A. Bredeson C. Camitta B. et al. (2011) Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. Biol Blood Marrow Transplant 17: 1018–1024.
11. Colombatti R. Maschietto N. Varotto E. Grison A. Grazzina N. Meneghello L. et al. (2010) Pulmonary hypertension in sickle cell disease children under 10 years of age. Br J Haematol 150: 601–609.
12. Dampier C. LeBeau P. Rhee S. Lieff S. Kesler K. Ballas S. et al. (2011) Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 86: 203–205.
13. Eapen M. Rubinstein P. Zhang M. Stevens C. Kurtzberg J. Scaradavou A. et al. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 369: 1947–1954.
14. Fitzhugh C. Lauder N. Jonassaint J. Telen M. Zhao X. Wright E. et al. (2010) Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 85: 36–40.
15. Fitzhugh C. Perl S. Hsieh M. (2008) Late effects of myeloablative bone marrow transplantation (BMT) in sickle cell disease (SCD). Blood 111: 1742–1743.
16. Franceschi L. Cappellini M. Olivieri O. (2011) Thrombosis and sickle cell disease. Semin Thromb Hemost 37: 226–236.
17. Gladwin M. Sachdev V. Jison M. Shizukuda Y. Plehn J. Minter K. et al. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Eng J Med 350: 886–895.
18. Hebbel R. (2011) Reconstructing sickle cell disease: a data-based analysis of the ‘hyperhemolysis paradigm’ for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol 86: 123–154.
19. Hingorani S. Seidel K. Lindner A. Aneja T. Schoch G. McDonald G. (2008) Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 14: 1365–1372.
20. Hoppe C. Walters M. (2001) Bone marrow transplantation in sickle cell anemia. Curr Opin Oncol 13: 85–90.
21. Horan J. Liesveld J. Fenton P. Blumberg N. Walters M. (2005) Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant 35: 171–177.
22. Horan J. Wang T. Haagenson M. Spellman S. Dehn J. Eapen M. et al. (2012) Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood 120: 2918–2924.
23. Hsieh M. Kang E. Fitzhugh C. Link B. Bolan C. Kurlander R. et al. (2009) Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 361: 2309–2317.
24. Hsieh M. Wu C. Tisdale J. (2011) In mixed hematopoietic chimerism, the donor red cells win. Haematologica 96: 13–15.
25. Hulbert M. McKinstry R. Lacey J. Moran C. Panepinto J. Thompson A. et al. (2011) Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood 117: 772–779.
26. Iannone R. Casella J. Fuchs E. Chen A. Jones R. Woolfrey A. et al. (2003) Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 9: 519–528.
27. Jacobsohn D. Duerst R. Tse M. Kletzel M. (2004) Reduced intensity hematopoietic stem-cell transplantation. Lancet 364: 156–162.
28. Jiang T. Yang C. Hung I. Chen S. Sun C. Chow R. (2007) Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 40: 307–311.
29. Kalinyak K. Morris C. Ball W. Ris M. Harris R. Rucknagel D. (1995) Bone marrow transplantation in a young child with sickle cell anemia. Am J Hematol 48: 256–261.
30. Kamani N. Walters M. Carter S. Aquino V. Brochstein J. Chaudhury S. et al. (2012) Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant 18: 1265–1272.
31. Kinney T. Sleeper L. Wang W. Zimmerman R. Pegelow C. Ohene-Frempong K. et al. (1999) Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 97: 864–870.
32. Kodish E. Lantos J. Stocking C. Singer P. Siegler M. Johnson F. (1991) Bone marrow transplantation for sickle cell disease. A study of parents’ decisions. N Eng J Med 325: 1349–1353.
33. Krishnamurti L. Abel S. Maiers M. Flesch S. (2003) Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplant 31: 547–550.
34. Krishnamurti L. Blazar B. Wagner J. (2001) Bone marrow transplantation without myeloablation for sickle cell disease. N Engl J Med 344: 68.
35. Krishnamurti L. Kharbanda S. Biernacki M. Zhang W. Baker K. Wagner J. et al. (2008) Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 14: 1270–1278.
36. Kwiatkowski J. Yim E. Miller S. Adams R. ; Stop 2 Study Investigators (2011) Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer 56: 777–782.
37. Lisini D. Zecca M. Giorgiani G. Montagna D. Cristantielli R. Labirio M. et al. (2008) Donor / recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica 93: 1859–1867.
38. Locatelli F. Rocha V. Reed W. Bernaudin F. Ertem M. Grafakos S. et al. (2003) Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101: 2137–2143.
39. Mentzer W. Heller S. Pearle P. Hackney E. Vichinsky E. (1994) Availability of related donors for bone marrow transplantation in sickle cell anemia. Am J Pediatr Hematol Oncol 16: 27–29.
40. Ohene-Frempong K. Weiner S. Sleeper L. (1998) Cerebrovascular accidents in sickle cell disease rates and risk factors. Blood 91: 288–294.
41. Page K. Zhang L. Mendizabal A. Wease S. Carter S. Gentry T. et al. (2011) Total colony-forming units are a strong independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant 17: 1362–1374.
42. Parsons S. Phipps S. Sung L. Baker K. Pulsipher M. Ness K. (2012) NCI, NHLBI / PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant 18: 162–171.
43. Platt O. Brambilla D. Rosse W. Milner P. Castro O. Steinberg M. et al. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330: 1639–1644.
44. Quinn C. Lee N. Shull E. Ahmad N. Rogers Z. Buchanan G. (2008) Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newbron Cohort. Blood 111: 544–548.
45. Quinn C. Rogers Z. Buchanan G. (2004) Survival of children with sickle cell disease. Blood 103: 4023–4027.
46. Quinn C. Rogers Z. McCavit T. Buchanan G. (2010) Improved survival of children and adolescents with sickle cell disease. Blood 115: 3447–3452.
47. Reed W. Walters M. Trachtenberg E. Smith R. Lubin B. (2001) Sibling donor cord blood banking for children with sickle cell disease. Pediatr Pathol Mol Med 20: 167–174.
48. Rizzo J. Curtis R. Socié G. Sobocinski K. Gilbert E. Landgren O. et al. (2009) Solid cancers after allogeneic hemtopoietic cell transplantation. Blood 113: 1175–1183.
49. Ruggeri A. Eapen M. Scaravadou A. Cairo M. Bhatia M. Kurtzberg J. et al. (2011) Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 17: 1375–1382.
50. Scothorn D. Price C. Schwartz D. (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140: 348–354.
51. Shaw P. Kan F. Woo Ahn K. Spellman S. Aljurf M. Ayas M. et al. (2010) Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood 116: 4007–4015.
52. Shenoy S. (2011) Hematopoietic stem cell transplantation for sickle cell disease: current practice and emerging trends. Hematology Am Soc Hematol Educ Program 2011: 273–279.
53. Shenoy S. Grossman W. DiPersio J. Yu L. Wilson D. Barnes Y. et al. (2005) A novel reduced-intensity stem cell transplant regimen for non-malignant disorders. Bone Marrow Transplant 35: 345–352.
54. van Besien K. Bartholomew A. Stock W. Peace D. Devine S. Sher D. et al. (2000) Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant 26: 445–449.
55. van Besien K. Koshy M. Anderson-Shaw L. Talishy N. Dorn L. Devine S. et al. (2001) Allogeneic stem cell transplantation for sickle cell disease. A study of parents’ decisions. Bone Marrow Transplant 28: 545–549.
56. Vermylen C. Cornu G. Ferster A. Brichard B. Ninane J. Ferrant A. et al. (1998) Hematopoietic stem cell transplantation for sickle cell anemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 22: 1–6.
57. Walters M. Hardy K. Edwards S. Adamkiewicz T. Barkovich J. Bernaudin F. et al. (2010) Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant 16: 263–272.
58. Walters M. Patience M. Leisenring W. Rogers Z. Aquino V. Buchanan G. et al. (2001) Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 7: 665–673.
59. Walters M. Quirolo L. Trachtenberg E. Edwards S. Hale L. Lee J. et al. (2005) Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci 1054: 206–213.
60. Walters M. Sullivan K. Bernaudin F. Souillet G. Vannier J. Johnson F. et al. (1995) Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 85: 879–884.
61. Woodard P. Helton K. Khan R. Hale G. Phipps S. Wang W. et al. (2005) Brain parenchymal damage after hematopoietic stem cell transplantation for severe sickle cell disease. Br J Haematol 129: 550–552.